Docetaxel

Krajina: Nový Zéland

Jazyk: angličtina

Zdroj: Medsafe (Medicines Safety Authority)

Aktívna zložka:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

Dostupné z:

REX Medical Ltd

INN (Medzinárodný Name):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

Dávkovanie:

80 mg/mL

Forma lieku:

Concentrate for infusion

Zloženie:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Počet v balení:

Vial, glass, Diluent, 6 mL

Trieda:

Prescription

Typ predpisu:

Prescription

Výrobca:

Cipla Ltd

Terapeutické indikácie:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Prehľad produktov:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Dátum Autorizácia:

2006-06-23